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Background 
Patients presenting to the Emergency Department (ED) with acute heart failure (AHF) represent 
a heterogeneous group in terms of clinical presentation, pathophysiology, and prognosis, with 
symptoms ranging from a mild increase in their baseline exertional dyspnea to severe 
cardiogenic shock. Rapidly distinguishing AHF from other common causes of dyspnea is the 
cornerstone to appropriate management and risk-stratification. When ED physicians base their 
diagnosis of AHF on history and physical exam only, misdiagnosis rates may be as high as 
33%.1 Ancillary testing helps, but even after chest radiography and natriuretic peptide testing 
the diagnosis may still be unclear in 15-20% of patients.2-4 Little has changed, in terms of 
ancillary testing, in the past two decades to help physicians in the ED rapidly diagnose and then 
appropriately treat AHF in the ED. 
 
Patients with prior episodes of AHF have undergone assessment of left ventricular performance 
and are characterized as having a reduced LVEF (HFrEF) or preserved LVEF (HFpEF) based 
on this.  This information was often obtained once hospitalized after the ED phase of 
management, providing little help to physicians who are involved with the initial diagnosis and 
management of the patient. We believe a focused bedside ultrasound assessment during an 
AHF episode at the time of ED presentation would assist with acute management, improve ED 
diagnostic accuracy, and direct initial therapeutic decisions in these complex patients who 
present with undifferentiated symptoms.  
The ACCF/AHA Heart Failure Guidelines state that 2-D ECHO with Doppler is the most 
important diagnostic test to answer three fundamental questions: 1) Is the LVEF preserved or 
reduced? 2) Is structure normal or abnormal? 3) Are there other structural abnormalities that 
might contribute to the HF?5 While these recommendations were not intended for the ED 
setting, we hypothesize that such knowledge could have potentially important diagnostic and 
therapeutic value in the ED (Table 1).  Indeed, a recent consensus document suggests focused 
cardiac ultrasound should be used to establish the diagnosis of AHF and its potential 
etiologies.6 The European Association of Cardiovascular Imaging (EACVI) recognizes the utility 
of clinician performed focused cardiac ultrasound in the ED and intensive care unit as an 
important and viable way to assess patients who present with signs or symptoms of cardiac 
dysfunction. Knowledge of LV function and identification of specific cardiac structural 
abnormalities, such as severe mitral regurgitation or aortic stenosis, are important for clinicians 
when choosing the initiation and type of IV vasoactive therapies for patients presenting with 
AHF. Identification of other conditions, including pericardial or pleural effusion would also 
change the therapeutic approach. 
Regardless of when or where patients present with AHF, a standard approach for diagnosing 
and treating AHF is important. Many precipitants and etiologies are established with laboratory 
testing (infarction, worsening renal function), chest radiography (pneumonia) and clinical history 
(dietary and medication indiscretion). However, clinician performed bedside cardiopulmonary 
ultrasound allows the clinician to identify the relevant pathophysiology, identify other precipitants 
and etiologies, and assess the heart from a physiologic perspective. Therefore, we believe a 
strategic approach that is generalizable and can be accomplished rapidly in the ED is 
necessary.  
Rapid Assessment of Pulmonary Congestion, Central Venous Filling Pressures and 
Ejection Fraction in Dyspneic ED Patients using Cardiopulmonary Ultrasound. 
We suggest a new paradigm in the approach to the patient who presents with signs and 
symptoms of AHF, one that uses EP performed bedside ultrasound measures of left ventricular 
performance and congestion to not only diagnose AHF, but to tailor treatment and disposition 
decisions.  This focused approach, incorporated into the traditional ED work-up, is referred to as 
the Cardiopulmonary Assessment in Real-time to Determine Diastolic and Systolic function with 
Sonography (CARDDSS) exam.(Figure 1) 
As part of the CARDDSS exam, we propose four step-by-step sonographic elements that can 
help differentiate AHF from other causes of dyspnea by assessing for pulmonary edema, central 
venous congestion, assessing for elevated left ventricular end diastolic pressure (LVEDP) and 
broadly differentiating between HFrEF and HFpEF. 
Step 1: Pulmonary Ultrasound to assess for pulmonary vascular congestion: 
Pulmonary ultrasound has been well described in the emergency and critical care literature in 
patients with dyspnea and respiratory failure7-10 and has been shown to be accurate in detecting 
AHF with reported sensitivities of 86-100% and specificities of 95-98%.9,10 Lungs that have 
increased interstitial or alveolar edema produce characteristic sonographic comet tail artifacts 
known as B-lines that arise from the visceral-parietal lung interface, extend to the bottom of the 
viewing field, move with respiration, are less than 7mm apart and erase the reverberation 
artifacts referred to as A-lines. Lungs that have 3 or more B-lines per viewing field are 
pathologic and constitute a condition known as alveolar interstitial syndrome (AIS) which can be 
focal and unilateral (e.g. pneumonia) or diffuse and bilateral (e.g. pulmonary edema). Any 
condition that causes fluid buildup in the lymphatic interlobular septae at the pleural surface will 
cause AIS. Thus limiting the ability of pulmonary ultrasound alone to discriminate between AHF 
from other causes of pulmonary edema.  
Step 2: IVC size and collapsibility to estimate CVP: 
Sonographic assessment of IVC size and collapsibility is the most frequently used non-invasive 
technique for estimation of right sided filling pressures.11 It is routinely performed with the 
patient in a supine position at end expiration and during a deep inhalation12. Using these 
parameters, IVC size and Collapsibility Index (CI = IVCD max- IVCD min/IVCD max) have been 
shown in a number of studies to correlate with right atrial pressure, 13 pulmonary capillary wedge 
pressure, 12 and risk for hospital readmission for AHF. 14 
IVC size and collapsibility is known to vary as much as 40% based on patient positioning alone. 
Fortunately, studies by EPs of ED patients in an upright position suggest the IVC collapsibility 
index yields strong diagnostic accuracy to predict AHF with optimal cut-off values of 1 cm for 
maximal IVC diameter and a CI of less than 15-33%. 15-17  
Step 3: Doppler Interrogation of Left sided filling pressures 
The American and European cardiology and echocardiography societies recommend tissue 
Doppler (TD) be used in combination with MV inflow velocities to determine if patients with 
normal systolic function have AHF.18 Tissue and flow Doppler provides non-invasive measures 
of the driving pressure needed to move blood into the LV.  Early diastolic lengthening velocities 
(e’), measured and averaged at the septal and lateral portion of the MV annulus, used in 
combination with peak early (E) flow velocities across the mitral valve have been used to 
identify elevated LVEDP. The ratio of “E” to “e’” (E/e’) correlates closely with LV filling 
pressures. There is a strong correlation in patients with HFpEF, and a moderate correlation in 
HFrEF, when E/e’>15. 19 
Performing and interpreting MV inflow and TD patterns is the most difficult part of our proposed 
algorithm and is beyond the scope of many EPs who are not trained to perform this type of 
exam. We expect most of the subjects in our proposed algorithm will have AHF diagnosed prior 
to proceeding to this step and thus will not need Doppler interrogation of MV inflow velocities. 
However, studies done by EP have found this to feasible and accurate.  
Step 4: Differentiating between preserved and reduced LVEF 
Once the diagnosis of AHF has been established, assessment of LV function should 
differentiate between the two different phenotypes of AHF. Various M-mode methods of LVEF 
estimation including E-point septal separation, mitral annular plane systolic excursion, fractional 
shortening, and visual estimation are established methods EP have used to estimate LVEF.  
Thus, LVEF estimations are placed in broad categories of normal, moderately reduced and 
severely reduced 20-22 according to recommendations by both the American College of 
Emergency Physicians (ACEP) and the American Society of Echocardiography (ASE).21  
From a theoretical perspective, initial treatment of AHF patients with HFpEF should be different 
than those with HFrEF. Patients with HFpEF have higher filling pressures as a result of 
ventricular stiffness, rather than volume overload, which may be seen more often in patients 
with HFrEF. AHF patients with hypertension, many of whom have HFpEF, have a 
pathophysiology that is dominated by fluid redistribution into the lower pressure pulmonary 
vascular bed rather than an absolute increase in intravascular volume.23-25 As a result, 
aggressive use of vasodilators in patients with HFpEF to decrease ventricular preload and 
afterload is key to improving cardiac output and removing fluid from the pulmonary vascular 
bed. Many patients with HFrEF cannot tolerate benefit from diuresis, but aggressive vasodilation 
could result in hypotension.  
Training and Competency in Performing and Interpreting Focused Cardiopulmonary 
Ultrasound 
In the past decade, training and use of ultrasound by clinicians of many different specialties has 
dramatically increased. EACVI supports the use of focused and goal directed cardiac ultrasound 
(referred to as FoCUS by EACVI) in the evaluation of patients presenting with signs and 
symptoms of acute cardiac dysfunction regardless of specialty, as long as these physicians 
have received appropriate training.26,27 Similarly, ACEP and ASE have also established 
guidelines that support using focused cardiac ultrasound in the ED.28-14 These and other 
professional societies have recognized the value that ultrasound provides to clinicians during 
the early stages of diagnosis and treatment of multiple diseases, including AHF. Focused 
cardiac ultrasound is by nature limited, goal directed and focused. It is not a replacement for 
comprehensive echocardiography, but rather serves as a means to improve the efficiency and 
accuracy of care in the ED when patients present with signs and symptom of acute cardiac 
dysfunction. 
Future Investigations with Focused ED Ultrasound 
While preliminary data suggests our conceptual model may improve patient care in ED patients 
with AHF, we propose 3 formal investigations to quantify this impact. First, a diagnostic 
algorithm, such as the one we propose, should be compared with the traditional “clinical 
assessment” model of EP diagnosis. This would allow quantification of the incremental 
improvement in diagnostic accuracy provided by bedside ultrasound. Second, once patients 
have been diagnosed as AHF, goal directed therapy can be assessed. The impact of diuretics 
and vasodilators on patient’s ultrasound findings of congestion could be followed over time. 
Preliminary data suggests vasodilators may be more beneficial in patients with HFpEF, but 
changes in cardiac function and congestion on ultrasound would help delineate the most 
efficacious approach. Our third and final proposed study would evaluate the incremental 
prognostic information obtained on bedside ultrasound in the ED. While prior and in-hospital EF 
and natriuretic peptides have been shown to be prognostic, measures of LVEF and congestion 
based on bedside ultrasound have not been incorporated into risk models or ED-based decision 
making. Comparing ED-based decision making with and without knowledge of ultrasound 
findings, and incorporating these findings into predictive instruments would be important to 
quantify.  
Conclusion 
In summary, knowledge of initial cardiac structure, function, and hemodynamics in ED patients 
with AHF may have an impact on diagnostic accuracy, treatment selection, and perhaps risk-
stratification. It may also contribute to identification of AHF etiologies and precipitants. We 
suggest a combined approach of clinical examination, laboratory testing, chest radiography, and 
focused cardiopulmonary ultrasound examinations following the steps outlined in the proposed 
CARDDSS exam. This proposed algorithm, while in need of prospective testing, can be 
performed rapidly at the bedside and may improve the management and outcomes of patients 
inn the ED with AHF. 
 
 Table 1. Comparison of focused ED cardiac ultrasound with comprehensive echocardiography. 
 ECHO Modalities Goals of ECHO Limitations  
ED Presentation Focused-TTE 
M Mode, Color and 
Spectral Doppler, 
TDI 
-Diagnosis of AHF 














TTE and TEE 





-Detection of Ischemia 
or new focal wall motion 
abnormalities 
-Detection of contractile 
reserve 
-Candidates for cardiac 
surgery 




time to perform 
test 
-Inability to send  
unstable patients 
to ECHO suite 
TTE – transthoracic echocardiogram; TEE- transesophageal echocardiogram; TDI- tissue 
Doppler index; RT3DE- real time three dimensional echocardiography 
 
 Table 3. Interpreting results of the CARDDSS exam to assist with differentiating AHF from other acute 
pathophysiology, as well as characterizing the underlying pathophysiology in AHF. 
 P I E/e’>15 EF<45 
Chronic HF, check BNP - - - + 
PE,RV MI, congenital - + + - 
RV dysf>LV dysf - + +/- + 
LV dysf+low volume status - - + + 
Acute MR + - + - 
Noncardiac  + - - - 
Chronic LV decompensation + - - + 
Right decompensation with pre-
existing LV decompensation 
- + - + 
AHF Unlikely - - +/- - 
PE- pulmonary embolism; RV- right ventricular; LV- left ventricular; MR- mitral regurgitation; AHF- 
acute heart failure
 Figure 1. Proposed CARDDSS algorithm for determining signs of AHF and HFpEF or HFrEF in 
dyspneic ED patients. 
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